Sinopharm
Sahpra registers Sinopharm, Pfizer COVID-19 vaccines for use in SA
South African Health Products Regulatory Authority (Sahpra) spokesperson, Yuven Gounden, said that the regulator had received all the required data on the...
-
China approves first mixed-vaccine trial as Delta spreads
The World Health Organization has said there is still not enough data to say whether using two different vaccines together is safe or can boost immunity.
-
Libya calls on public to get COVID vaccination
Since the pandemic began, Libya has recorded 256,328 cases and 3,579 deaths from COVID-19.
-
COVID vaccines, fake negative tests now sold on the darknet: BBC
According to the BBC, prices range between R7,400 and R11,000 for doses of AstraZeneca, Sputnik, Sinopharm or Johnson & Johnson jabs.
-
Zimbabwe to receive 800,000 Sinopharm shots by March
The country will be among the first on the continent to start its inoculation with the Chinese-made vaccine.
-
South Africans in China love its efficient COVID-19 response, but racism remains
Beijing-based South African English teachers say an efficient public service and an obedient citizenry have allowed China to control the spread of COVID-19 better than most countries.
-
More than 100 million vaccinated across the globe
None of the world's 29 poorest countries has formally started mass vaccination drives, while the richest nations have given more than two-thirds of jabs administered.
-
Pfizer or Sinopharm? 'Vaccine diplomacy' in Middle East
In the Middle East and North Africa, novel coronavirus vaccine orders are driven by diplomatic and logistical considerations, reflecting Beijing's growing regional influence.
-
Dubai ruler joins COVID-19 vaccine trial
Two vaccines are undergoing third-phase trials in the UAE, one produced by Chinese drug giant Sinopharm, and Russia's Sputnik-V, named after the Soviet-era satellite.
-
Peru, Morocco to test China Sinopharm's COVID-19 vaccine in Phase 3 trial
Phase 3 trials, which usually involve several thousand participants, allow researchers to gather data on the efficacy of potential vaccines for final regulatory approvals.
